7-Bromo-2-methyl-2,3-dihydropyrazolo[5,1-b]oxazole, 97%, 1g

3-tert-butyl-1H-pyrazole-5-carbohydrazide, 97%, 5g

(4-Methoxy-3-nitrophenyl)methanol, 95.0%, 5g

2-Aminobenzo[d]thiazole-5-carbonitrile, 95.0%, 100mg

(R)-1-(3-Chlorophenyl)propan-1-amine hydrochloride, 95.0%, 250mg

Hexane (isomers), min. 95% (isomers), for synthesis, 2.5 L, glass packaging

5,6,7,8-Tetrahydro-1,6-naphthyridin-2(1H)-one, 95.0%, 100mg

(2R,5R)-tert-Butyl 5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate, 95.0%, 500mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(1-(tert-butoxycarbonyl)piperidin-4-yl)butanoic acid, 97%, 1g

1,2-Bis[(2R,5R)-2,5-dimethylphospholano]benzene>98.0%(GC)500mg

Methyl 3-chloro-5-(N-(4,6-difluoro-[1,1'-biphenyl]-3-yl)sulfamoyl)-4-hydroxybenzoate, 98.0%, 50mg

Sample tub SpecTainer, 90 ml, Sterile, 400 Piece(s)

3-Chloro-5-nitroaniline, 95.0%, 10g